TD Cowen analyst Ritu Baral maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report) today and set a price target of $35.00.

TD Bank Group ("TD" or the "Bank") (TSX: TD) (NYSE: TD) announced today that it expects zero catastrophe claims after reinsurance and before tax to be reflected in the Bank's Wealth Management & ...

Hodoyan, Vice President, Investor Relations at QUALCOMM You can access our earnings release and a slide presentation that ...

Needham reaffirmed its Buy rating on DraftKings Inc. (NASDAQ: NASDAQ:DKNG) with a steady price target of $60. The endorsement comes despite the firm lowering its fourth-quarter estimates due to ...